Skip to main content

and
  1. No Access

    Article

    Urinary elimination of salsolinol enantiomers in alcoholics

    The analysis of the urine from 6 chronic alcoholics showed that (R)-and (S)-salsolinol were detectable in 4 subjects, the R enantiomer was only found in one and that both enantiomers were under the limit of de...

    P. Dostert, M. Strolin Benedetti, G. Dordain in Journal of Neural Transmission / General S… (1991)

  2. No Access

    Article

    Biosynthesis of salsolinol, a tetrahydroisoquinoline alkaloid, in healthy subjects

    The R enantiomer of salsolinol was detected in the urine of two out of six healthy subjects, whereas 1,2-dehydrosalsolinol was present in the urine of all the subjects. (S)-salsolinol was never detected. Admin...

    P. Dostert, M. Strolin Benedetti in Journal of Neural Transmission / General S… (1990)

  3. No Access

    Chapter

    Urinary excretion of salsolinol enantiomers and 1,2-dehydrosalsolinol in patients with degenerative dementia

    The daily urinary excretion of total (R)- and (S)-salsolinol and 1,2-dehydrosalsolinol (free + sulfoconjugate) was measured in patients with degenerative dementia. (R)-Salsolinol was detectable in the urine of...

    Dr. P. Dostert, M. Strolin Benedetti in Alzheimer’s Disease. Epidemiology, Neuropa… (1990)

  4. No Access

    Chapter

    Salsolinol and the early detection of Parkinson’s disease

    In a previous study, the daily urinary excretion of total (R + S) salsolinol was shown to be significantly lower in de novo parkinsonian patients than in healthy volunteers.

    P. Dostert, M. Strolin Benedetti, G. Dordain in Early Markers in Parkinson’s and Alzheimer… (1990)

  5. No Access

    Article

    Enantiomeric composition of urinary salsolinol in Parkinsonian patients after Madopar

    Urinary salsolinol output had been shown to be lower in Parkinsonian patients than in controls and to increase largely after L-dopa therapy. It had also been established that the R enantiomer of salsolinol is ...

    Dr. P. Dostert, M. Strolin Benedetti in Journal of Neural Transmission - Parkinson… (1989)

  6. No Access

    Article

    Chronopharmacokinetic and bioequivalence studies of two formulations of trimipramine after oral administration in man

    The bioavailability of two oral formulations of trimipramine, tablets and solution, was performed in twelve healthy volunteers, in a cross-over study. Each formulation was administered in the morning after a f...

    A. M. Bougerolle, J. L. Chabard, M. Jbilou in European Journal of Drug Metabolism and Ph… (1989)

  7. No Access

    Article

    Urinary excretion of salsolinol enantiomers in patients with degenerative dementia

    P. Dostert, M. Strolin Benedetti in Journal of Neural Transmission - Parkinson… (1989)

  8. No Access

    Article

    Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseases

    Tetrahydroisoquinoline (TIQ) alkaloids and 1-carboxy TIQ derivatives have been found in human fluids and/or tissues. The possible biosynthetic pathways of salsolinol (Sal), taken as an example of TIQs, are dis...

    P. Dostert, M. Strolin Benedetti, G. Dordain in Journal of Neural Transmission (1988)

  9. No Access

    Chapter and Conference Paper

    Methodology of a Controlled Trial in Alzheimer’s Disease

    Various evaluation scales suggested for studying the clinical evolution of Alzheimer-type dementias are discussed, and the practical aspects of a controlled clinical trial are considered.

    H. Dehen, G. Dordain, M. Allard in Rökan (1988)

  10. No Access

    Article

    Kinetics of metapramine and its demethylated metabolites after single and chronic oral administration in man

    The kinetics of metapramine and two of its demethylated metabolites were determined in six normal subjects after oral administration of a single 150 mg dose on day 1 and 3 × 50 mg dose on day 2–6. This study h...

    A. M. Bougerolle, J. L. Chabard, G. Dordain in European Journal of Drug Metabolism and Ph… (1986)

  11. No Access

    Article

    Effect of a reversible and selective MAO-A inhibitor (cimoxatone) on diurnal variation in plasma prolactin level in man

    Prolactin (PRL) secretion is stimulated by serotonin (5-HT) and inhibited by dopamine (DA). 5-HT is generally recognized as a substrate for type A monoamine oxidase (MAO), whereas DA is considered as a substra...

    M. Strolin Benedetti, A. Eschalier, A. Lesage in European Journal of Clinical Pharmacology (1984)

  12. No Access

    Article

    The frequency of relapse in multiple sclerosis

    The authors analyze the course of 245 cased of multiple sclerosis. The mean annual frequency of attacks is 0.66 for all the patients (remittent forms and progressive forms). Although it is usually suggested th...

    F. Lhermitte, R. Marteau, J. Gazengel, G. Dordain, G. Deloche in Zeitschrift für Neurologie (1973)